Targeted amplification of alternating electric fields using ferroelectric nanoparticles.

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Electric field (e-field) therapies, such as tumor-treating fields (TTFields), show promise for non-invasive cancer treatment.
• Current e-field therapies face challenges including limited tissue penetration, poor spatial targeting, and potential thermal effects.

Purpose of the Study:

• To develop surface-engineered tetragonal phase barium titanate nanoparticles (tBTO NPs) capable of amplifying local e-fields for enhanced cancer therapy.
• To evaluate the efficacy and safety of tBTO NPs in overcoming the limitations of existing e-field treatments.

Main Methods:

• Surface modification of tBTO NPs for stable dispersion and targeted delivery in biological settings.
• Comparative analysis of tBTO NPs against non-ferroelectric gold nanoparticles and cubic phase BTO NPs.
• Utilizing super-resolution microscopy and single-cell tracking to quantify cellular responses to amplified e-fields.

Main Results:

• tBTO NPs demonstrated enhanced microtubule disruption and cell growth inhibition compared to control nanoparticles, highlighting the importance of ferroelectricity.
• Surface modifications ensured biocompatibility, achieving stable dispersion and targeted delivery without significant cytotoxicity.
• Quantitative analysis revealed that amplified e-fields significantly perturbed cellular behaviors, including migration, proliferation, and morphology.

Conclusions:

• Surface-engineered tBTO NPs offer a novel approach to amplify e-fields, potentially overcoming limitations of current TTFields therapy.
• These ferroelectric nanoparticles represent a promising advancement in nanomaterial-based bioelectronic cancer therapies and precision medicine.
• The findings suggest a broader application of electromagnetic technologies in targeted cancer treatment strategies.